A detailed history of First City Capital Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, First City Capital Management, Inc. holds 20,945 shares of BMY stock, worth $1.21 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
20,945
Previous 18,825 11.26%
Holding current value
$1.21 Million
Previous $781,000 38.67%
% of portfolio
0.56%
Previous 0.45%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$39.66 - $51.75 $84,079 - $109,710
2,120 Added 11.26%
20,945 $1.08 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $318,256 - $418,991
-7,907 Reduced 29.58%
18,825 $781,000
Q1 2024

May 22, 2024

BUY
$47.98 - $54.4 $56,184 - $63,702
1,171 Added 4.58%
26,732 $1.45 Million
Q4 2023

Feb 07, 2024

SELL
$48.48 - $57.85 $29,766 - $35,519
-614 Reduced 2.35%
25,561 $1.31 Million
Q3 2023

Oct 26, 2023

SELL
$57.89 - $64.73 $2,026 - $2,265
-35 Reduced 0.13%
26,175 $1.52 Million
Q2 2023

Jul 19, 2023

SELL
$63.71 - $70.74 $65,111 - $72,296
-1,022 Reduced 3.75%
26,210 $1.68 Million
Q1 2023

May 01, 2023

SELL
$65.71 - $74.53 $788 - $894
-12 Reduced 0.04%
27,232 $1.89 Million
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $73,068 - $86,523
-1,067 Reduced 3.77%
27,244 $1.96 Million
Q3 2022

Oct 24, 2022

SELL
$0.13 - $76.84 $3 - $1,921
-25 Reduced 0.09%
28,311 $2.01 Million
Q2 2022

Jul 21, 2022

SELL
$72.62 - $79.98 $9,077 - $9,997
-125 Reduced 0.44%
28,336 $2.18 Million
Q1 2022

May 04, 2022

BUY
$61.48 - $73.72 $33,445 - $40,103
544 Added 1.95%
28,461 $2.08 Million
Q4 2021

Feb 07, 2022

SELL
$53.63 - $62.52 $326,070 - $380,121
-6,080 Reduced 17.88%
27,917 $1.81 Million
Q3 2021

Oct 28, 2021

SELL
$59.17 - $69.31 $1,952 - $2,287
-33 Reduced 0.1%
33,997 $2.01 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $11,762 - $12,809
-190 Reduced 0.56%
34,030 $2.28 Million
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $57,797 - $65,004
974 Added 2.93%
34,220 $2.21 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $1.66 Million - $1.88 Million
-28,789 Reduced 46.41%
33,246 $1.99 Million
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $1.67 Million - $1.85 Million
29,073 Added 88.2%
62,035 $3.74 Million
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $49,557 - $57,937
904 Added 2.82%
32,962 $1.94 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $122,774 - $178,419
-2,646 Reduced 7.62%
32,058 $1.79 Million
Q4 2019

Feb 10, 2020

SELL
$49.21 - $64.19 $67,614 - $88,197
-1,374 Reduced 3.81%
34,704 $2.23 Million
Q3 2019

Nov 13, 2019

SELL
$42.77 - $50.71 $57,867 - $68,610
-1,353 Reduced 3.61%
36,078 $1.83 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $3,569 - $3,947
-80 Reduced 0.21%
37,431 $1.7 Million
Q1 2019

May 13, 2019

SELL
$45.12 - $53.8 $40,608 - $48,420
-900 Reduced 2.34%
37,511 $1.79 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $46,370 - $60,131
-951 Reduced 2.42%
38,411 $2 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $38,633 - $43,575
-700 Reduced 1.75%
39,362 $2.44 Million
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $7,326 - $9,132
-145 Reduced 0.36%
40,062 $2.22 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $22,170 - $25,522
-370 Reduced 0.91%
40,207 $2.54 Million
Q4 2017

Feb 12, 2018

SELL
$59.94 - $65.35 $8,991 - $9,802
-150 Reduced 0.37%
40,577 $2.49 Million
Q3 2017

Oct 31, 2017

SELL
$55.23 - $63.74 $44,184 - $50,992
-800 Reduced 1.93%
40,727 $2.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
41,527
41,527 $2.31 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track First City Capital Management, Inc. Portfolio

Follow First City Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First City Capital Management, Inc. with notifications on news.